-
1
-
-
0035103299
-
A unique microvascular phenotype shared by juvenile hemangiomas and human placenta
-
Boye E, Yu Y, Paranya G, Mulliken JB, et al. - A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. J Clin Invest, 2001, 107, 745-752.
-
(2001)
J Clin Invest
, vol.107
, pp. 745-752
-
-
Boye, E.1
Yu, Y.2
Paranya, G.3
Mulliken, J.B.4
-
2
-
-
0035007197
-
Clonality and altered behavior of endothelial cells from hemangiomas
-
North PE, Waner M, Mizeracki A, et al. - Clonality and altered behavior of endothelial cells from hemangiomas. Arch Dermatol, 2001, 137, 559-570.
-
(2001)
Arch Dermatol
, vol.137
, pp. 559-570
-
-
North, P.E.1
Waner, M.2
Mizeracki, A.3
-
3
-
-
0020574495
-
Kasabach Meritt syndrome in infants
-
Esterly NB. - Kasabach Meritt syndrome in infants. J Am Acad Dermatol, 1983, 8, 504-513.
-
(1983)
J Am Acad Dermatol
, vol.8
, pp. 504-513
-
-
Esterly, N.B.1
-
4
-
-
0025273317
-
Management of alarming hemangiomas in infancy : A review of 25 cases
-
Enjolras O, Riche MC, Merland JJ, Escande JP. - Management of alarming hemangiomas in infancy : a review of 25 cases. Pediatrics, 1990, 85, 491-498.
-
(1990)
Pediatrics
, vol.85
, pp. 491-498
-
-
Enjolras, O.1
Riche, M.C.2
Merland, J.J.3
Escande, J.P.4
-
5
-
-
0031917719
-
Spastic diplagia as a complication of interferon alfa-2a treatment of hemangiomas of infancy
-
Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, et al. - Spastic diplagia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr, 1998, 132, 527-530.
-
(1998)
J Pediatr
, vol.132
, pp. 527-530
-
-
Barlow, C.F.1
Priebe, C.J.2
Mulliken, J.B.3
Barnes, P.D.4
-
6
-
-
0026345003
-
The clinical pharmacology and use of anti microtubule agents in cancer chemotherapeutics
-
Rowinsky EK, Donehower RC. - The clinical pharmacology and use of anti microtubule agents in cancer chemotherapeutics. Pharmacol Ther, 1991, 52, 35-84.
-
(1991)
Pharmacol Ther
, vol.52
, pp. 35-84
-
-
Rowinsky, E.K.1
Donehower, R.C.2
-
7
-
-
0029058511
-
Treatment of life threatening hemangiomas with vincristine
-
Payarols JP, Masferrer JP, Bellvert CG. - Treatment of life threatening hemangiomas with vincristine. New Engl J Med, 1995, 333, 69.
-
(1995)
New Engl J Med
, vol.333
, pp. 69
-
-
Payarols, J.P.1
Masferrer, J.P.2
Bellvert, C.G.3
-
8
-
-
0036265364
-
Vincristine-an effective treatment of cortico-resistant life threatening infantile hemangiomas
-
Perez J, Pardo J, Gomez C. - Vincristine-an effective treatment of cortico-resistant life threatening infantile hemangiomas. Acta Oncol, 2002, 41, 197-199.
-
(2002)
Acta Oncol
, vol.41
, pp. 197-199
-
-
Perez, J.1
Pardo, J.2
Gomez, C.3
-
9
-
-
0036694371
-
Kasabach-Meritt phenomenon : A retrospective study of treatment with vincristine
-
Haisley-Royster C, Enjorlas O, Frieden IJ, Garzon M. - Kasabach-Meritt phenomenon : a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol, 2002, 24, 459-462.
-
(2002)
J Pediatr Hematol Oncol
, vol.24
, pp. 459-462
-
-
Haisley-Royster, C.1
Enjorlas, O.2
Frieden, I.J.3
Garzon, M.4
-
10
-
-
1242294351
-
Traitement par vincristine des hémangiomes graves du nourrisson.
-
Enjorlas O, Brevière GM, Roger G, Tovi M, et al. - Traitement par vincristine des hémangiomes graves du nourrisson. Arch Fr Ped, 2004, 11, 99-107.
-
(2004)
Arch Fr Ped
, vol.11
, pp. 99-107
-
-
Enjorlas, O.1
Brevière, G.M.2
Roger, G.3
Tovi, M.4
|